R. Loch Macdonald

2016

In 2016, R. Loch Macdonald earned a total compensation of $974.5K as Chief Scientific Officer at Edge Therapeutics, a 62% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$175,500
Option Awards$409,005
Salary$390,000
Total$974,505

Macdonald received $409K in option awards, accounting for 42% of the total pay in 2016.

Macdonald also received $175.5K in non-equity incentive plan and $390K in salary.

Rankings

In 2016, R. Loch Macdonald's compensation ranked 8,373rd out of 14,075 executives tracked by ExecPay. In other words, Macdonald earned more than 40.5% of executives.

ClassificationRankingPercentile
All
8,373
out of 14,075
41st
Division
Manufacturing
3,208
out of 5,489
42nd
Major group
Chemicals And Allied Products
1,077
out of 1,895
43rd
Industry group
Drugs
841
out of 1,538
45th
Industry
Pharmaceutical Preparations
667
out of 1,176
43rd
Source: SEC filing on April 25, 2018.

Macdonald's colleagues

We found two more compensation records of executives who worked with R. Loch Macdonald at Edge Therapeutics in 2016.

2016

Brian Leuthner

Edge Therapeutics

Chief Executive Officer

2016

Herbert Faleck

Edge Therapeutics

Chief Medical Officer

News

You may also like